Logo Logo
Help
Contact
Switch language to German
Sorafenib resistance of hepatocellular carcinoma. antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption
Sorafenib resistance of hepatocellular carcinoma. antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption
Not available
Not available
Meßner, Martina
2020
English
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Meßner, Martina (2020): Sorafenib resistance of hepatocellular carcinoma: antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption. Dissertation, LMU München: Faculty of Chemistry and Pharmacy
[img]
Preview
PDF
Messner_Martina.pdf

22MB